Albemarle to Increase Prices of ETHACURE(R) Curatives

    BATON ROUGE, La., Aug. 19 /EMWNews/ -- Specialty chemicals

maker Albemarle Corporation (NYSE: ALB), a leading global manufacturer of

liquid curing agents for epoxy, polyurethane and polyurea systems for

coatings, reaction-injection-molded (RIM) parts and other applications,

will increase the prices of select ETHACURE curatives worldwide effective

September 1, 2008, or as contracts allow.



    



    The prices of ETHACURE 100 and ETHACURE 100 LC curatives will increase

by $0.35/lb worldwide. The price of ETHACURE 300 curative will increase by

$0.30/lb worldwide.



    ETHACURE curatives are manufactured in the U.S.A., and are part of

Albemarle's Polymer Additives business segment. For more information about

ETHACURE curatives, visit http://www.ethacure.com.



    Albemarle Corporation, headquartered in Baton Rouge, La., is a leading

global developer, manufacturer and marketer of highly engineered specialty

chemicals for consumer electronics; petroleum and petrochemical processing;

transportation and industrial products; pharmaceuticals; agricultural

products; and construction and packaging materials. The Company operates in

three business segments -- Polymer Additives, Catalysts and Fine Chemicals

-- serves customers in approximately 100 countries. Learn more about

Albemarle at http://www.albemarle.com.



    Forward-Looking Statements:



    Portions of this release constitute forward-looking statements within

the meaning of the Private Securities Litigation Reform Act of 1995.

Although Albemarle Corporation believes its expectations reflected in the

release are based on reasonable assumptions within the bounds of its

knowledge of its business and operations; there can be no assurance that

actual results will not differ materially. Factors that could cause actual

results to differ from expectations include, without limitation, the

inability to pass through increases in costs and expenses for raw materials

and energy; competition from other manufacturers; changes in demand for our

products; the gain or loss of significant customers; fluctuations in

foreign currencies and increased government regulation of our operations or

our products. Additional factors that could cause Albemarle's results to

differ materially from those described in the forward-looking statements

can be found under "Risk Factors" in item 1A of our Annual Report for the

period ended December 31, 2007.